Search

Insulet Corp

Abierto

SectorSanidad

167.09 1.33

Resumen

Variación precio

24h

Actual

Mínimo

164.31

Máximo

172.83

Métricas clave

By Trading Economics

Ingresos

-11M

91M

Ventas

-22M

762M

P/B

Media del Sector

38.3

62.58

BPA

1.42

Margen de beneficios

11.96

Empleados

5,400

EBITDA

-23M

154M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+34.17% upside

Dividendos

By Acuity

Próximas Ganancias

5 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-278M

12B

Apertura anterior

165.76

Cierre anterior

167.09

Noticias sobre sentimiento de mercado

By Acuity

63%

37%

295 / 340 Clasificación en Healthcare

Insulet Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 jul 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24 jul 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22 jul 2026, 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20 jul 2026, 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Comparación entre iguales

Cambio de precio

Insulet Corp previsión

Precio Objetivo

By TipRanks

34.17% repunte

Estimación a 12 Meses

Media 221.38 USD  34.17%

Máximo 294 USD

Mínimo 172 USD

De acuerdo con 22 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Insulet Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

22 ratings

18

Comprar

3

Mantener

1

Vender

Sentimiento

By Acuity

295 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat